Miller-Fisher syndrome
👁️🧠 Miller Fisher Syndrome (MFS) is a rare variant of Guillain-Barré Syndrome (GBS), strongly associated with anti-GQ1b antibodies. Unlike typical GBS, it primarily affects the eyes and coordination rather than causing widespread limb weakness.
ℹ️ About
- 🔹 Accounts for ~5% of Guillain-Barré cases.
- 🔹 Defined by the classic triad: ophthalmoplegia, ataxia, and areflexia.
- 🔹 Weakness is usually absent, distinguishing it from typical GBS.
- 🔹 Often post-infectious (e.g., following Campylobacter jejuni or viral illness).
🩺 Clinical Features
- 👀 Ophthalmoplegia: Diplopia and restricted eye movements, often the first presenting symptom.
- ⚖️ Ataxia: Gait imbalance and impaired coordination, usually without limb weakness.
- 🔔 Areflexia: Absent tendon reflexes despite preserved motor strength.
- 😀 Cranial nerve involvement may cause mild facial weakness or bulbar symptoms.
- ❗ Rarely, symptoms can progress into classical GBS with limb or respiratory involvement, so monitoring is vital.
Differential Diagnosis
- 🎯 Myasthenia Gravis (MG): Fluctuating weakness, no areflexia.
- 🧴 Botulism: Ocular involvement but descending paralysis and autonomic dysfunction dominate.
- 💉 Diphtheria: Cranial neuropathies but with systemic illness.
- 🕷️ Tick paralysis: Ascending paralysis, history of tick bite.
- 🌸 Sarcoidosis: Granulomatous cranial neuropathies, with systemic signs (lungs, skin, eyes).
🔎 Investigations
- 🧪 Anti-GQ1b antibodies: Positive in ~90% – highly specific for MFS.
- 💉 CSF: Albuminocytologic dissociation (↑protein, normal WCC) similar to GBS.
- ⚡ EMG/Nerve Conduction Studies: May show mild demyelination, less than in typical GBS.
- 🩻 Neuroimaging (MRI brain): Performed to rule out brainstem pathology if atypical features.
💊 Management
- 💉 IV Immunoglobulin (IVIg): Mainstay therapy, accelerates recovery.
- 🔄 Plasma Exchange: Alternative to IVIg, useful in severe or progressive disease.
- 🫁 Supportive Care: Monitor for respiratory compromise, as ~5% progress to classical GBS.
- 🦵 Rehabilitation: Physiotherapy and occupational therapy aid recovery and function.
Prognosis
- 🌟 Generally excellent – most recover fully within 8–12 weeks.
- 🧪 Anti-GQ1b positivity is both a diagnostic and prognostic marker.
- ⚠️ Relapse is rare but can occur; long-term disability is uncommon.
Cases - Miller–Fisher Syndrome
- Case 1 - Classic Triad 👁️:
A 40-year-old man presents 2 weeks after a flu-like illness with double vision, unsteady gait, and numbness around his mouth. Exam: bilateral ophthalmoplegia, ataxia, and areflexia. Limb strength is preserved.
Diagnosis: Miller–Fisher syndrome.
Management: Admit for monitoring; IV immunoglobulin (IVIG); supportive physiotherapy. Prognosis usually excellent.
- Case 2 - Bulbar Involvement 🗣️:
A 55-year-old woman develops progressive diplopia, slurred speech, and unsteadiness. Exam: ophthalmoplegia, dysarthria, limb areflexia, wide-based gait. Anti-GQ1b antibodies positive.
Diagnosis: MFS with bulbar involvement.
Management: IVIG; swallowing assessment; neuro-rehab input; monitor for respiratory decline.
- Case 3 - Overlap with GBS ⚡:
A 33-year-old man presents with acute diplopia and ataxia after diarrhoeal illness. Over days, he develops mild ascending limb weakness in addition to the triad. CSF: albuminocytologic dissociation.
Diagnosis: Miller–Fisher syndrome overlapping with Guillain–Barré syndrome.
Management: IVIG or plasma exchange; respiratory monitoring; MDT rehabilitation.
Teaching Commentary 🧠
Miller–Fisher syndrome is a rare GBS variant, typically presenting with the triad of ophthalmoplegia, ataxia, and areflexia, but with preserved limb strength.
- Often follows infection (Campylobacter, viral).
- Anti-GQ1b antibodies strongly associated.
- CSF: albuminocytologic dissociation (raised protein, normal cells).
- NCS: reduced sensory action potentials, abnormal brainstem reflexes.
Management = IVIG or plasma exchange + supportive therapy. Prognosis is usually good, with recovery in weeks–months.
